BioCardia (BCDA) Gross Margin (2011 - 2021)

BioCardia (BCDA) has reported Gross Margin for 9 consecutive years, with 100.0% the latest figure, recorded in Q4 2021.

• On a quarterly basis, Gross Margin changed 0.0% year-over-year to 100.0% in Q4 2021; TTM through Dec 2021 was 100.0%, a 276.0% increase from a year earlier, with the FY2021 full-year figure at 100.0%, up 276.0% from the prior year.
• Gross Margin was 100.0% for Q4 2021 at BioCardia, roughly flat from 100.0% in the prior quarter.
• Over five years, Gross Margin peaked at 100.0% in Q2 2020 and troughed at 122.09% in Q2 2019.
• A 5-year average of 32.84% and a median of 50.93% in 2019 frame the typical range for Gross Margin.
• Across the five-year window, Gross Margin slumped 16561 bps in 2019 and surged 22209 bps in 2020, its largest moves.
• Over 5 years, Gross Margin stood at 65.0% in 2017, then jumped by 81 bps to 12.62% in 2018, then surged by 756 bps to 82.79% in 2019, then grew by 21 bps to 100.0% in 2020, then changed by 0 bps to 100.0% in 2021.
• The last three Gross Margin figures came in at 100.0% (Q4 2021), 100.0% (Q3 2021), and 100.0% (Q2 2021), per Business Quant data.